what is a semaglutide The Weight Loss Program: & Tirzepatide for Effective Results What to Expect During the

Insert the needle into the pinch at a 90-degree angle (45 degrees if the fat layer is thin) [13] [14]

About Dexcom Terms & Policies Information MAT-5161 LBL-1005236 Rev001 2026 Dexcom, Inc

Longer subscription commitments (such as 6-month or 10-month plans paid upfront) typically result in lower monthly rates

Starting semaglutide smoothly Start at a low dose and escalate gradually to improve tolerability

Abbreviations ADA: Adenosine deaminase ADVANCE: Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Afib: Atrial fibrillation BNP: Brain natriuretic peptide cAMP: Cyclic adenosine 3,5-monophosphate CI: Confidence interval CKD: Chronic kidney disease CVD: Cardiovascular disease CVOTs: Cardiovascular outcome trials DPP-4: Dipeptidyl peptidase-4 DPP-4i: DPP-4 inhibitor eGFR: Estimated glomerular filtration rate FDA: Food and Drug Administration GAS: Interferon-gamma-activated sequence GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide-1 GLP-1R: GLP-1 receptor GLP-1RAs: Glucagon-like peptide-1 receptor agonists HbA1c: Glycated hemoglobin HDL: High-density lipoprotein HF: Heart failure HNF-1: Hepatocyte nuclear factor-1 HR: Hazard ratio hs-CRP: High-sensitivity C-reactive protein IL-12: Interleukin-12 IVUS: Intravascular ultrasound LDL: Low-density lipoprotein LVEF: Left ventricular ejection fraction MACE: Major adverse cardiovascular events MI: Myocardial infarction MMPs: Matrix metalloproteases PAI-1: Plasminogen activator inhibitor-1 PCI: Percutaneous coronary intervention PKA: Protein kinase A PWV: Pulse wave velocity SGLT-2i: Sodium/glucose cotransporter-2 inhibitors STAT1: Signal transducer and activator of transcription 1 T1DM: Type 1 diabetes mellitus T2DM: Type 2 diabetes mellitus TGF-: Transforming growth factor- TLR4: Toll-like receptor 4 TNF-: Tumor necrosis factor- TRIF: TIR-domain-containing adapter-inducing interferon- UKPDS: United Kingdom Prospective Diabetes Study VLDL: Very low-density lipoprotein References Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al